Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Wound Repair Regen ; 20(5): 731-9, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22823522

RESUMO

Deep partial thickness burn (DPTB) wound fluids have a greater propensity for establishing neovascularization than did superficial partial thickness burn (SPTB) wound fluids in our previous study. To investigate the factors responsible for this activity, cytokine array and enzyme-linked immunosorbent assay were used to perform an expression analysis of angiogenic factors in burn fluid. Although present in approximately equal amounts in both SPTB and DPTB blister fluids from burn patients, angiogenin does appear to be involved in the ability of DPTB blister fluid to promote neovascularization in vitro and in vivo. Angiogenin alone was sufficient to induce endothelial differentiation of circulating angiogenic cells (CAC) without vascular endothelial growth factor A involvement. In addition, angiogenin was positively associated with CAC differentiation in the burn blister fluid. Blocking the effect of angiogenin in burn blister fluids resulted in a significant reduction of endothelial cell proliferation, CAC differentiation, and new blood vessels formation in vivo. Moreover, immunohistochemistry revealed that high angiogenin expression colocalizes with high vascularity in human burn wounds at day 7, further supporting our hypothesis that angiogenin is involved in burn wound neovascularization.


Assuntos
Vesícula/metabolismo , Queimaduras/metabolismo , Cicatriz/metabolismo , Exsudatos e Transudatos/metabolismo , Neovascularização Fisiológica , Ribonuclease Pancreático/metabolismo , Cicatrização , Queimaduras/fisiopatologia , Proliferação de Células , Células Cultivadas , Cicatriz/etiologia , Células Endoteliais , Ensaio de Imunoadsorção Enzimática , Humanos , Imuno-Histoquímica , Estudos Retrospectivos , Ribonuclease Pancreático/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa